The multiverse nature of epithelial to mesenchymal transition.


Journal

Seminars in cancer biology
ISSN: 1096-3650
Titre abrégé: Semin Cancer Biol
Pays: England
ID NLM: 9010218

Informations de publication

Date de publication:
10 2019
Historique:
received: 29 09 2018
revised: 09 11 2018
accepted: 15 11 2018
pubmed: 20 11 2018
medline: 9 4 2020
entrez: 20 11 2018
Statut: ppublish

Résumé

The epithelial mesenchymal transition (EMT) program is defined as a cellular transition from an epithelial to a mesenchymal state. This process occurs to provide the cell with new phenotypic assets and new skills to perform complex processes. EMT is regulated at multilayer levels, including transcriptional control of gene expression, regulation of RNA splicing, and translational/post-translational control. Although transcriptional regulation by EMT-inducing transcription factors (EMT-TFs), including Zeb, Snail and Slug members, is generally considered the master step in this process, emerging data indicate that all these regulatory networks may have a role in the control of EMT. There is a sort of parallelism between the biological and still unrevealed EMT complexity and the cosmological hypothesis that sustains the universe may exist as a multiverse. The presence of different EMT transition states together with the occurrence of multiple layers of regulation support the idea that EMT is just one on many out there. Is the activation of a single layer of regulation sufficient to initiate the whole EMT program? Can we postulate the activation of different EMT "dimensions"? If we think about these layers as multiple separate "universes", various scenarios can be revealed.

Identifiants

pubmed: 30453041
pii: S1044-579X(18)30086-5
doi: 10.1016/j.semcancer.2018.11.004
pii:
doi:

Substances chimiques

Transcription Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-10

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Pasquale Simeone (P)

Department of Medicine and Aging Sciences, "G.d'Annunzio" University of Chieti-Pescara, Italy; Center on Aging Science and Translational Medicine (Cesi-MeT), "G.d'Annunzio" University of Chieti-Pescara, Italy.

Marco Trerotola (M)

Department of Medical, Oral and Biotechnological Sciences, "G.d'Annunzio" University of Chieti-Pescara, Italy; Center on Aging Science and Translational Medicine (Cesi-MeT), "G.d'Annunzio" University of Chieti-Pescara, Italy.

Julien Franck (J)

University of Lille, Inserm, U-1192, Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse-PRISM, F-59000, Lille, France.

Tristan Cardon (T)

University of Lille, Inserm, U-1192, Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse-PRISM, F-59000, Lille, France.

Marco Marchisio (M)

Department of Medicine and Aging Sciences, "G.d'Annunzio" University of Chieti-Pescara, Italy; Center on Aging Science and Translational Medicine (Cesi-MeT), "G.d'Annunzio" University of Chieti-Pescara, Italy.

Isabelle Fournier (I)

University of Lille, Inserm, U-1192, Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse-PRISM, F-59000, Lille, France.

Michel Salzet (M)

University of Lille, Inserm, U-1192, Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse-PRISM, F-59000, Lille, France.

Michele Maffia (M)

Department of Biological and Environmental Sciences and Technologies, University of Salento, Lecce, Italy; Laboratory of Clinical Proteomic, "Giovanni Paolo II'' Hospital, ASL-Lecce, Italy.

Daniele Vergara (D)

Department of Biological and Environmental Sciences and Technologies, University of Salento, Lecce, Italy; Laboratory of Clinical Proteomic, "Giovanni Paolo II'' Hospital, ASL-Lecce, Italy. Electronic address: daniele.vergara@unisalento.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH